How Biotech Went from “No Way” to Payday in the Cannabis Business

May 14, 2019

(MIT Technology Review) – Melo isn’t alone. As biotechnology embraces the legal cannabis industry, not a few of its executives are grappling with a dilemma: what will it mean if they make the drug much easier to get? So far, 33 US states have legalized medical marijuana, and 10 of these also permit recreational use. In October 2018, Canada permitted pot sales nationally. Health Canada expects that its citizens will consume 926,000 kilograms of cannabis this year, or one to two billion joints’ worth. Most will be consumed by daily pot smokers, who make up about 5% of Canada’s adult population, according to the agency.

Recommended Reading